| [1] |
McLeod NM, Pratt CA, Mellor TK，et al. Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis，the Portsmouth experience[J]. Br J Oral Maxillofac Surg，2012，50(1):41-44.
|
| [2] |
Vissink A, Burlage FR, Spijkervet FK，et al. Prevention and treatment of the consequences of head and neck radiotherapy[J]. Crit Rev Oral Biol Med，2003，14(3):213-225.
|
| [3] |
Balogh JM, Sutherland SE. Osteoradionecrosis of the mandible：a review[J]. J Otolaryngol，1989，18(5):245-250.
|
| [4] |
Delanian S, Lefaix JL. Radionécrose de l′os mature：connaissance physiopathologique récente motrice d′une thérapeutique médicale innovante[J]. Cancer/Radiother，2002，6(1):1-9.
|
| [5] |
Cochran WG. The combination of estimates from different experiments[J]. Biometrics，1954，10(1):101-129.
|
| [6] |
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis[J]. Stat Med，2002，21(11):1539-1558.
|
| [7] |
DerSimonian R, Laird N. Meta-analysis in clinical trials[J]. Control Clin Trials，1986，7(3):177-188.
|
| [8] |
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease[J]. J Natl Cancer Inst，1959，22(4):719-748.
|
| [9] |
D′Souza J, Lowe D, Rogers SN. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible：experience from a regional head and neck unit[J]. Br J Oral Maxillofac Surg，2014，52(4):356-362.
|
| [10] |
Robard L, Louis MY, Blanchard D，et al. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO：preliminary results[J]. Eur Ann Otorhinolaryngol Head Neck Dis，2014，131(6):333-338.
|
| [11] |
Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol：a phaseⅡ trial[J]. Head Neck，2005，27(2):114-123.
|
| [12] |
Delanian S, Chatel C, Porcher R，et al. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination（PENTOCLO）：a phaseⅡ trial[J]. Int J Radiat Oncol Biol Phys，2011，80(3):832-839.
|
| [13] |
Patel V, Gadiwalla Y, Sassoon I，et al. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis[J]. Br J Oral Maxillofac Surg，2016，54(3):342-345.
|
| [14] |
O′Dell K, Sinha U. Osteoradionecrosis[J]. Oral Maxillofac Surg Clin North Am，2011，23(3):455-464.
|
| [15] |
Meyer OT, Dannenberg AM Jr. Radiation，infection，and macrophage function.Ⅱ. Effect of whole body radiation on the number of pulmonary alveolar macrophages and their levels of hydrolytic enzymes[J]. J Reticuloendothel Soc，1970，7(1):79-90.
|
| [16] |
Marx RE. A new concept in the treatment of osteoradionecrosis[J]. J Oral Maxillofac Surg，1983，41(6):351-357.
|
| [17] |
Annane D, Depondt J, Aubert P，et al. Hyperbaric oxygen therapy for radionecrosis of the jaw：a randomized，placebo-controlled，double-blind trial from the ORN96 study group[J]. J Clin Oncol，2004，22(24):4893-4900.
|
| [18] |
何悦，刘忠龙，代天国，等.放射性下颌骨坏死的BS临床分类及治疗策略[J].中国肿瘤临床，2015，42(16):817-826.
|
| [19] |
Shaw RJ, Dhanda J. Hyperbaric oxygen in the management of late radiation injury to the head and neck. PartⅠ：treatment[J]. Br J Oral Maxillofac Surg，2011，49(1):2-8.
|
| [20] |
Shaw RJ, Butterworth C. Hyperbaric oxygen in the management of late radiation injury to the head and neck. PartⅡ：prevention[J]. Br J Oral Maxillofac Surg，2011，49(1):9-13.
|
| [21] |
Madrid C, Abarca M, Bouferrache K. Osteoradionecrosis：an update[J]. Oral Oncology，2010，46(6):471-474.
|
| [22] |
Lyons A, Ghazali N. Osteoradionecrosis of the jaws：current understanding of its pathophysiology and treatment[J]. Br J Oral Maxillofac Surg，2008，46(8):653-660.
|
| [23] |
何悦，代天国，孙坚，等.血管化骨组织瓣在下颌骨放射性骨坏死临床治疗中的应用研究[J].中国肿瘤临床，2015，42(16):827-833.
|
| [24] |
Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol[J]. Br J Radiol，1998，71(848):892-894.
|
| [25] |
Delanian S, Ballamekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol[J]. J Clin Oncol，1999，17(10):3283-3290.
|
| [26] |
Kaya V, Yazkan R, Yıldırım M，et al. The relation of radiation-induced pulmonary fibrosis with stress and the efficiency of antioxidant treatment：an experimental study[J]. Med Sci Monit，2014(20):290-296.
|
| [27] |
Okunieff P, Augustine E, Hicks JE，et al. Pentoxifylline in the treatment of radiation-induced fibrosis[J]. J Clin Oncol，2004，22(11):2207-2213.
|
| [28] |
Delanian S, Lefaix JL. The radiation-induced fibroatrophic process：therapeutic perspective via the antioxidant pathway[J]. Radiother Oncol，2004，73(2):119-131.
|
| [29] |
Delanian S, Porcher R, Balla-Mekias S，et al. Randomized，placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis[J]. J Clin Oncol，2003，21(13):2545-2550.
|
| [30] |
宗春琳，郭宇轩，窦庚，等.兔下颌骨放射性骨坏死模型的建立及评估[J].中国口腔颌面外科杂志，2014，12(6):481-486.
|
| [31] |
付洪海，周咏，张志愿，等. TGF-β1过表达介导的放疗诱导成纤维细胞向肌成纤维细胞分化的体外研究[J].中国口腔颌面外科杂志，2012，10(4):266-270.
|
| [32] |
Zong C, Cai B, Wen X，et al. The role of myofibroblasts in the development of osteoradionecrosis in a newly established rabbit model[J]. J Craniomaxillofac Surg，2016，44(6):725-733.
|
| [33] |
Chen Y, Zong C, Guo Y，et al. Hydrogen-rich saline may be an effective and specific novel treatment for osteoradionecrosis of the jaw[J]. Ther Clin Risk Manag，2015(11):1581-1585.
|